But a deal spanning two countries isn't just a bigger version of a domestic one. It carries legal exposure, tax complexity, cultural risk, and communications challenges that most US-only playbooks don't anticipate.
This guide walks through why companies pursue cross-border M&A, how to diligence a foreign target properly, how deal structure affects liability, and how to communicate the transaction to investors and employees without losing their trust.
Key Takeaways
- Cross-border deals need a clear strategic rationale before target selection begins
- Diligence must cover legal, financial, and cultural risk, not just the balance sheet
- Deal structure (stock vs. asset) determines exactly what liabilities transfer to the buyer
- Stakeholder communications deserve the same rigor as legal and financial workstreams
- Regulatory and tax review can stretch timelines well past six months
What Is Cross-Border M&A and Why Companies Pursue It
Cross-border M&A happens when the acquirer and target are headquartered in different countries. That single fact changes almost everything about how teams diligence, structure, and close a deal.
Companies pursue these deals for a handful of reasons:
- Market access: Enter a new country without building infrastructure from scratch
- Strategic assets: Acquire IP, technology, or specialized talent unavailable at home
- Supply chain diversification: Reduce dependence on a single region
- Competitive positioning: Close a capability gap before a rival does
Amgen's 2023 acquisition of Dublin-based Horizon Therapeutics is a clear example. Amgen, headquartered in Thousand Oaks, California, closed the $116.50-per-share deal to strengthen its inflammation portfolio.
It also aimed to leverage existing biologics manufacturing and R&D footprint across more than 100 countries, with accelerated revenue growth expected from 2024.
This isn't just a big-pharma story. Small- and mid-cap public companies, private growth companies, and businesses preparing for an IPO or SPAC are increasingly competing for the same global assets.
Many do it without the in-house deal teams large multinationals keep on staff.
Key Benefits and Challenges of Cross-Border Transactions
Benefits Companies Are Seeking
When a cross-border deal goes right, companies typically gain:
- Immediate access to new customers and distribution networks
- Faster market entry than building organic operations
- Acquisition of strategic IP, technology, or specialized talent pools
- Diversified revenue streams across currencies and economic cycles
Challenges That Can Derail a Deal
Those gains come with real execution risk. Common failure points include:
- Multi-jurisdictional regulatory complexity that slows approvals
- Cultural and operational integration risk post-close
- Currency fluctuation and political volatility
- Hidden liabilities buried in unfamiliar local business practices
Integration risk is not theoretical. In a Deloitte survey of 126 global life-sciences executives with direct cross-border M&A experience, respondents ranked culture, decision-making, and integration design above technical or financial issues as sources of value erosion. Deloitte notes that problems often begin with drifting decisions and undefined authority, not spreadsheet errors.
Conducting Three-Dimensional Due Diligence
Cross-border deals demand diligence across three distinct dimensions. Skipping any one of them is how deals unravel after signing.
Legal and Regulatory Diligence
This starts with foreign investment screening. In the US, CFIUS review can range from a 30-day declaration to a 45-day notice review, plus a possible additional 45-day investigation. Employment law differences matter just as much. Inherited contracts, works councils, and transfer rules (like TUPE in the UK) can obligate a buyer to retain staff and terms it never negotiated.
Financial and Commercial Diligence
Audited financials under local accounting standards rarely map cleanly onto US GAAP assumptions. Add data privacy regimes like GDPR into the mix, and commercial diligence becomes a compliance exercise as much as a financial one. Testing market assumptions against a purely US playbook is a common, costly mistake.
Cultural Diligence
Communication styles, decision-making hierarchies, and work/life norms differ by country. These are the most commonly underestimated factors in post-close integration. A founder who assumes their management style will translate seamlessly abroad is setting up for friction within months. Covering all three dimensions also raises execution cost. Budget 5-10% of enterprise value for combined legal, tax, and advisory work; cross-border deals routinely cost more to run properly than domestic deals of similar size.
Structuring the Deal and Managing Regulatory Complexity
Stock Purchase vs. Asset Purchase
The structure decision determines exactly what a buyer inherits:
| Structure | What Transfers | Key Risk |
|---|---|---|
| Stock purchase | Entire entity, including known and unknown liabilities | Buyer assumes hidden obligations |
| Asset purchase | Specified assets and liabilities only | Requires contract-by-contract novation |
According to Morgan Lewis, a stock buyer generally can't cherry-pick which liabilities it assumes, while an asset purchase lets a buyer specify exactly what transfers. Asset deals also trigger IRS Form 8594, which allocates the purchase price across asset classes for tax purposes.
Tax Considerations
Deal structure and tax outcomes move together, so international tax advisors need to weigh in early on:
- Double taxation risk between jurisdictions
- Transfer pricing compliance under OECD guidelines
- Profit repatriation planning post-close
Regulatory Approval Timelines
Once structure and tax are locked, clearance timing becomes the critical path. Review bodies vary significantly by geography:
- US: HSR Phase I runs 30 days (15 for cash tender offers); a Second Request can extend review by months, and CFIUS may apply when a foreign buyer acquires a U.S. business
- EU: Phase I review takes 25 working days (90%+ of cases resolve here); Phase II can extend to 90 working days
- UK: CMA Phase 1 has a 40-working-day deadline; Phase 2 can run 24 weeks
- China: SAMR Phase I is up to 30 calendar days, Phase II up to 90, with a possible 60-day extension
Stack antitrust review, foreign investment screening, and sector-specific approvals together, and a deal can easily add several months to closing.
Communicating a Cross-Border Deal to Investors, Employees, and Media
Cross-border transactions carry heightened communications risk. Language barriers, unfamiliar disclosure regimes, and analyst skepticism about integration execution can all undermine confidence in a deal that looks solid on paper.
An effective announcement strategy needs:
- A clear equity story explaining the strategic rationale in terms investors and analysts can evaluate quickly
- Coordinated press outreach across every relevant geography, not just the acquirer's home market
- Consistent messaging tailored for investors, employees, and media without contradicting itself across audiences
This is where a lot of well-structured deals lose momentum. A management team that nails legal and financial diligence can still stumble if employees hear about the acquisition from a news article before hearing it from leadership.
Closing that gap takes the same discipline applied to legal and financial work. Gateway Group has supported transaction communications from pre-announcement through closing across more than 50 international client engagements. That cross-border perspective matters when a US company needs its equity story to land the same way with a domestic analyst as it does with employees and media in the other market.
A 90-day post-close integration communications plan is worth building before the deal even closes. Stakeholders—especially employees in the acquired entity—need a steady cadence of updates during the transition, or uncertainty will fill the gap on its own.
Frequently Asked Questions
What are the four types of acquisitions?
The common structures are stock-for-stock, all-cash, cash-and-stock, and asset purchases. In cross-border deals, stock-for-stock structures add currency and shareholder-approval complexity that all-cash deals avoid.
Is M&A part of investment banking?
Investment banks typically advise on deal sourcing, valuation, and financing structures. Specialized legal, tax, and communications advisors then support execution, especially for cross-border regulatory and stakeholder complexity.
How long does a typical cross-border M&A deal take to complete?
Most cross-border deals take 6-12+ months from announcement to close. Regulatory review timelines, like CFIUS, EU merger control, or UK CMA review, are usually the biggest variable.
What is the most common reason cross-border deals fail?
Underestimated liabilities uncovered during diligence, particularly around employment law and tax, are frequent culprits. Poor post-close cultural integration is another leading cause of value erosion.
What role do local advisors play in cross-border transactions?
Local legal, tax, and communications counsel identify region-specific risks that a US-based team may not anticipate, from employment transfer rules to local regulatory quirks. Baker McKenzie's global M&A guide covers nearly 40 jurisdictions for exactly this reason.
What is TUPE and why does it matter in cross-border deals?
TUPE is the UK's Transfer of Undertakings (Protection of Employment) regime. It automatically protects employees' jobs and terms when a business changes ownership, and it can apply even when the acquirer's head office sits outside the UK.
